Remove Biochemical Pharmacology Remove Clinical Development Remove Engineering
article thumbnail

Targeting the immunotherapy potential of cytokines IL-12 and IL-18 with new advancements in protein engineering

Drug Target Review

While the highly potent nature of their anti-tumour effects is widely established, clinical utility so far has been limited by severe challenges that persist despite extensive scientific inquiry across industry and academia. Some approaches have already reached the clinical trial stage, with others not far behind.